Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

$Case Study: Mechanism and Treatment of Refractory ISR$

Presentation TCT 2018

Case Study: Mechanism and Treatment of Refractory ISR

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

$Role of Brachytherapy for Refractory ISR in 2018$

Presentation TCT 2018

Role of Brachytherapy for Refractory ISR in 2018

Presenter: Fernando Alfonso, Azeem Latib, Ron Waksman

September 22, 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Presentation TCT 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Presenter: Fernando Alfonso, Azeem Latib, Juan F. Granada

September 22, 2018

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

Presentation TCT 2018

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

Presenter: Fernando Alfonso, Azeem Latib, Bruno Scheller

September 22, 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages – Theory and Evidence

Presentation TCT 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Presenter: Fernando Alfonso, Azeem Latib

September 22, 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presentation TCT 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presentation TCT 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne

September 22, 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

Acute scaffold thrombosis after percutaneous coronary intervention with Magmaris bioresorbable vascular scaffold

Presentation JIM 2018

Acute scaffold thrombosis after percutaneous coronary intervention with Magmaris bioresorbable vascular scaffold

Presenter: Athanasios Kolyviras

February 24, 2018

Magmaris: the impact of scaffold design and materials on lowering scaffold thrombosis

Presentation JIM 2018

Magmaris: the impact of scaffold design and materials on lowering scaffold thrombosis

Presenter: Michael Haude

February 23, 2018

Mechanisms and Predictors of BRS Thrombosis After 1 Year (With Case Demonstrations)

Presentation TCT 2017

Mechanisms and Predictors of BRS Thrombosis After 1 Year (With Case Demonstrations)

Presenter: Corrado Tamburino, Robert-Jan van Geuns, Joanna J. Wykrzykowska

November 01, 2017

Case Presentations: BRS Thrombosis Within 1 Year

Presentation TCT 2017

Case Presentations: BRS Thrombosis Within 1 Year

Presenter: Francesco Bedogni, Stephen G. Ellis, Julinda Mehilli

November 01, 2017

TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis – Multistudy Registry Results

Presentation TCT 2017

TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis Multistudy Registry Results

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Stephen G. Ellis

October 31, 2017

TCT 10: Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography - Insights From the International INVEST Registry

Presentation TCT 2017

TCT 10: Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography - Insights From the International INVEST Registry

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Lorenz Raber

October 31, 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

How to Manage BRS Thrombosis (With Case Examples)

Presentation TCT 2016

How to Manage BRS Thrombosis (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Anuruck Jeamanukoolkit

November 01, 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

Presentation TCT 2016

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.